SCHEMBL6710315

SCHEMBL6710315

CCCC(=O)Nc1cccc2cc(C(=O)Nc3ccc(Cl)cc3-c3nnn[nH]3)[nH]c12

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 3/20 0.39
▸ GAA P10253 1/20 0.39
▸ PLCG2 P16885 1/20 0.38
▸ PARP14 Q460N5 1/20 0.38
▸ ALDH1A1 P00352 2/20 0.37
▸ MAPT P10636 2/20 0.37
▸ LMNA P02545 1/20 0.37
▸ TP53 P04637 1/20 0.37
▸ GSK3B P49841 1/20 0.37
▸ PTK2B Q14289 1/20 0.37
▸ HDAC3 O15379 4/20 0.37
▸ HDAC1 Q13547 4/20 0.37
▸ NHERF1 O14745 2/20 0.37
▸ F2R P25116 1/20 0.37
▸ ADORA1 P30542 1/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ TDP1 Q9NUW8 1/20 0.36
▸ PYGL P06737 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6707884 0.95 HDAC3 (0.40) POLBPLCG2ALDH1A1MAPTLMNA
SCHEMBL6714199 0.94 HDAC3 (0.41) POLBPLCG2ALDH1A1MAPTLMNA
SCHEMBL6708858 0.94 HDAC3 (0.42) POLBPLCG2ALDH1A1MAPTLMNA
SCHEMBL6707825 0.94 HDAC3 (0.42) POLBPLCG2ALDH1A1MAPTLMNA
SCHEMBL6710087 0.93 PLCG2 (0.39) POLBPLCG2PARP14ALDH1A1MAPT
SCHEMBL6712420 0.90 PARP14 (0.38) POLBPARP14ALDH1A1MAPTLMNA
SCHEMBL6709211 0.90 PLCG2 (0.39) POLBPLCG2MAPTLMNATP53
SCHEMBL6711639 0.90 HDAC3 (0.40) POLBPLCG2MAPTLMNATP53
SCHEMBL6714114 0.89 ALOX15 (0.45) GAAPLCG2LMNAHDAC3HDAC1
SCHEMBL6714268 0.89 LMNA (0.39) POLBPLCG2ALDH1A1MAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 POLB 626/4885GAA 111/4885PLCG2 4289/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback